glp 1 agonist vs bariatric surgery The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after surgery: a systematic review and meta-analysis | Eating and Weight Disorders Bariatric Surgery vs GLP-1 Medications
Description
The threshold shift paradigm of obesity: evidence from surgically induced weight loss
The encouraging news is that in most cases, its temporary and reversible
Many GLP-1 patients (55.7%) lost over 10% of their body weight, while only 13.7% of metformin patients reached that threshold
Clinical Trials and Safety Profile: In 2006, dipeptidyl-peptidase-4 (DPP-4) inhibitors were launched for the treatment of type 2 diabetes
doi: 10.1016/j.molmet.2018.09.009
It varies by insurance provider and plan
